ERM transcription factor contains an inhibitory domain which functions in sumoylation-dependent manner

Biochimica et Biophysica Acta - Gene Regulatory Mechanisms

Volumn 1779, Issue 3, 2008, Pages 183-194

  Degerny, Cindy ^a   de Launoit, Yvan ^a   Baert, Jean Luc ^a  

^a CNRS   (France)

Author keywords

ERM; ETS; Regulation of transcription; SUMO; Transcription factor

Indexed keywords

PROTEIN VP16; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR ERM; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CIS TRANS ISOMERISM; CONTROLLED STUDY; DOWN REGULATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; SUMOYLATION; TRANSACTIVATION;

AMINO ACID SEQUENCE; ANIMALS; CELLS, CULTURED; CERCOPITHECUS AETHIOPS; COS CELLS; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION; PROTEIN STRUCTURE, TERTIARY; RABBITS; SUMO-1 PROTEIN; TRANSCRIPTION FACTORS;

EID: 40849085555     PISSN: 18749399     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbagrm.2008.01.002     Document Type: Article

References (53)

1. de Launoit Y., Baert J.L., Chotteau-Lelievre A., Monte D., Coutte L., Mauen S., Firlej V., Degerny C., and Verreman K. The Ets transcription factors of the PEA3 group: transcriptional regulators in metastasis. Biochim. Biophys. Acta 1766 (2006) 79-87
2. Kurpios N.A., Sabolic N.A., Shepherd T.G., Fidalgo G.M., and Hassell J.A. Function of PEA3 Ets transcription factors in mammary gland development and oncogenesis. J. Mammary Gland. Biol. Neoplasia 8 (2003) 177-190
3. Chotteau-Lelievre A., Montesano R., Soriano J., Soulie P., Desbiens X., and de Launoit Y. PEA3 transcription factors are expressed in tissues undergoing branching morphogenesis and promote formation of duct-like structures by mammary epithelial cells in vitro. Dev. Biol. 259 (2003) 241-257
4. Arber S., Ladle D.R., Lin J.H., Frank E., and Jessell T.M. ETS gene Er81 controls the formation of functional connections between group Ia sensory afferents and motor neurons. Cell 101 (2000) 485-498
5. Lin J.H., Saito T., Anderson D.J., Lance-Jones C., Jessell T.M., and Arber S. Functionally related motor neuron pool and muscle sensory afferent subtypes defined by coordinate ETS gene expression. Cell 95 (1998) 393-407
6. Chen C., Ouyang W., Grigura V., Zhou Q., Carnes K., Lim H., Zhao G.Q., Arber S., Kurpios N., Murphy T.L., Cheng A.M., Hassell J.A., Chandrashekar V., Hofmann M.C., Hess R.A., and Murphy K.M. ERM is required for transcriptional control of the spermatogonial stem cell niche. Nature 436 (2005) 1030-1034
7. Baert J.L., Monte D., Musgrove E.A., Albagli O., Sutherland R.L., and de Launoit Y. Expression of the PEA3 group of ETS-related transcription factors in human breast-cancer cells. Int. J. Cancer 70 (1997) 590-597
8. Chotteau-Lelievre A., Revillion F., Lhotellier V., Hornez L., Desbiens X., Cabaret V., de Launoit Y., and Peyrat J.P. Prognostic value of ERM gene expression in human primary breast cancers. Clin. Cancer Res. 10 (2004) 7297-7303
9. Davidson B., Goldberg I., Gotlieb W.H., Kopolovic J., Ben-Baruch G., and Reich R. PEA3 is the second Ets family transcription factor involved in tumor progression in ovarian carcinoma. Clin. Cancer Res. 9 (2003) 1412-1419
10. Netzer S., Leenders F., Dumont P., Baert J.L., and de Launoit Y. Ectopic expression of the ets transcription factor ER81 in transgenic mouse mammary gland enhances both urokinase plasminogen activator and stromelysin-1 transcription. Transgenic Res. 11 (2002) 123-131
11. Yang S.H., Shore P., Willingham N., Lakey J.H., and Sharrocks A.D. The mechanism of phosphorylation-inducible activation of the ETS-domain transcription factor Elk-1. Embo J. 18 (1999) 5666-5674
12. Kopp J.L., Wilder P.J., Desler M., Kinarsky L., and Rizzino A. Different domains of the transcription factor ELF3 are required in a promoter-specific manner and multiple domains control its binding to DNA. J. Biol. Chem. 282 (2007) 3027-3041
13. Lee G.M., Donaldson L.W., Pufall M.A., Kang H.S., Pot I., Graves B.J., and McIntosh L.P. The structural and dynamic basis of Ets-1 DNA binding autoinhibition. J. Biol. Chem. 280 (2005) 7088-7099
14. Pufall M.A., and Graves B.J. Autoinhibitory domains: modular effectors of cellular regulation. Annu. Rev. Cell Dev. Biol. 18 (2002) 421-462
15. Laget M.P., Defossez P.A., Albagli O., Baert J.L., Dewitte F., Stehelin D., and de Launoit Y. Two functionally distinct domains responsible for transactivation by the Ets family member ERM. Oncogene 12 (1996) 1325-1336
16. Bojovic B.B., and Hassell J.A. The PEA3 Ets transcription factor comprises multiple domains that regulate transactivation and DNA binding. J. Biol. Chem. 276 (2001) 4509-4521 (Electronic Publication 2000 Nov 28)
17. Yang S.H., Bumpass D.C., Perkins N.D., and Sharrocks A.D. The ETS domain transcription factor Elk-1 contains a novel class of repression domain. Mol. Cell. Biol. 22 (2002) 5036-5046
18. Stinson J., Inoue T., Yates P., Clancy A., Norton J.D., and Sharrocks A.D. Regulation of TCF ETS-domain transcription factors by helix-loop-helix motifs. Nucleic Acids Res. 31 (2003) 4717-4728
19. Nakae K., Nakajima K., Inazawa J., Kitaoka T., and Hirano T. ERM, a PEA3 subfamily of Ets transcription factors, can cooperate with c-Jun. J. Biol. Chem. 270 (1995) 23795-23800
20. Abdel-Hafiz H., Takimoto G.S., Tung L., and Horwitz K.B. The inhibitory function in human progesterone receptor N termini binds SUMO-1 protein to regulate autoinhibition and transrepression. J. Biol. Chem. 277 (2002) 33950-33956
21. Bies J., Markus J., and Wolff L. Covalent attachment of the SUMO-1 protein to the negative regulatory domain of the c-Myb transcription factor modifies its stability and transactivation capacity. J. Biol. Chem. 277 (2002) 8999-9009
22. Kim J., Cantwell C.A., Johnson P.F., Pfarr C.M., and Williams S.C. Transcriptional activity of CCAAT/enhancer-binding proteins is controlled by a conserved inhibitory domain that is a target for sumoylation. J. Biol. Chem. 277 (2002) 38037-38044
23. Yang S.H., Jaffray E., Hay R.T., and Sharrocks A.D. Dynamic interplay of the SUMO and ERK pathways in regulating Elk-1 transcriptional activity. Mol. Cell 12 (2003) 63-74
24. Sapetschnig A., Rischitor G., Braun H., Doll A., Schergaut M., Melchior F., and Suske G. Transcription factor Sp3 is silenced through SUMO modification by PIAS1. Embo J. 21 (2002) 5206-5215
25. Girdwood D., Bumpass D., Vaughan O.A., Thain A., Anderson L.A., Snowden A.W., Garcia-Wilson E., Perkins N.D., and Hay R.T. P300 transcriptional repression is mediated by SUMO modification. Mol. Cell 11 (2003) 1043-1054
26. Degerny C., Monte D., Beaudoin C., Jaffray E., Portois L., Hay R.T., de Launoit Y., and Baert J.L. SUMO modification of the Ets-related transcription factor ERM inhibits its transcriptional activity. J. Biol. Chem. 280 (2005) 24330-24338
27. Baert J.L., Beaudoin C., Coutte L., and de Launoit Y. ERM transactivation is up-regulated by the repression of DNA binding after the PKA phosphorylation of a consensus site at the edge of the ETS domain. J. Biol. Chem. 277 (2002) 1002-1012 (Electronic Publication 2001 Oct 26)
28. Defossez P.A., Baert J.L., Monnot M., and de Launoit Y. The ETS family member ERM contains an alpha-helical acidic activation domain that contacts TAFII60. Nucleic Acids Res. 25 (1997) 4455-4463
29. Maurer P., T'Sas F., Coutte L., Callens N., Brenner C., Van Lint C., de Launoit Y., and Baert J.L. FEV acts as a transcriptional repressor through its DNA-binding ETS domain and alanine-rich domain. Oncogene 22 (2003) 3319-3329
30. Iniguez-Lluhi J.A., and Pearce D. A common motif within the negative regulatory regions of multiple factors inhibits their transcriptional synergy. Mol. Cell. Biol. 20 (2000) 6040-6050
31. de Launoit Y., Audette M., Pelczar H., Plaza S., and Baert J.L. The transcription of the intercellular adhesion molecule-1 is regulated by Ets transcription factors. Oncogene 16 (1998) 2065-2073
32. Treier M., Staszewski L.M., and Bohmann D. Ubiquitin-dependent c-Jun degradation in vivo is mediated by the delta domain. Cell 78 (1994) 787-798
33. Johnson E.S. Protein modification by sumo. Annu. Rev. Biochem. 73 (2004) 355-382
34. Perdomo J., Verger A., Turner J., and Crossley M. Role for SUMO modification in facilitating transcriptional repression by BKLF. Mol. Cell. Biol. 25 (2005) 1549-1559
35. Hay R.T. SUMO: a history of modification. Mol Cell 18 (2005) 1-12
36. Cheng J., Wang D., Wang Z., and Yeh E.T. SENP1 enhances androgen receptor-dependent transcription through desumoylation of histone deacetylase 1. Mol. Cell. Biol. 24 (2004) 6021-6028
37. Sampson D.A., Wang M., and Matunis M.J. The small ubiquitin-like modifier-1 (SUMO-1) consensus sequence mediates Ubc9 binding and is essential for SUMO-1 modification. J. Biol. Chem. 276 (2001) 21664-21669
38. Maeda A., Lee B.H., Yoshimatsu K., Saijo M., Kurane I., Arikawa J., and Morikawa S. The intracellular association of the nucleocapsid protein (NP) of hantaan virus (HTNV) with small ubiquitin-like modifier-1 (SUMO-1) conjugating enzyme 9 (Ubc9). Virology 305 (2003) 288-297
39. Janknecht R. Analysis of the ERK-stimulated ETS transcription factor ER81. Mol. Cell. Biol. 16 (1996) 1550-1556
40. Holmstrom S., Van Antwerp M.E., and Iniguez-Lluhi J.A. Direct and distinguishable inhibitory roles for SUMO isoforms in the control of transcriptional synergy. Proc. Natl. Acad. Sci. U. S. A. 100 (2003) 15758-15763 (Electronic Publication 2003 Dec 8)
41. Chen W.Y., Lee W.C., Hsu N.C., Huang F., and Chung B.C. SUMO modification of repression domains modulates function of nuclear receptor 5A1 (steroidogenic factor-1). J. Biol. Chem. 279 (2004) 38730-38735 (Electronic Publication 2004 Jun 10)
42. Goel A., and Janknecht R. Acetylation-mediated transcriptional activation of the ETS protein ER81 by p300, P/CAF, and HER2/Neu. Mol. Cell. Biol. 23 (2003) 6243-6254
43. Papoutsopoulou S., and Janknecht R. Phosphorylation of ETS transcription factor ER81 in a complex with its coactivators CREB-binding protein and p300. Mol. Cell. Biol. 20 (2000) 7300-7310
44. Pastorcic M., and Das H.K. Analysis of transcriptional modulation of the presenilin 1 gene promoter by ZNF237, a candidate binding partner of the Ets transcription factor ERM. Brain Res. 1128 (2006) 21-32
45. Pastorcic M., and Das H.K. The C-terminal region of CHD3/ZFH interacts with the CIDD region of the Ets transcription factor ERM and represses transcription of the human presenilin 1 gene. Febs J. 274 (2007) 1434-1448
46. Hecker C.M., Rabiller M., Haglund K., Bayer P., and Dikic I. Specification of SUMO1- and SUMO2-interacting motifs. J. Biol. Chem. 281 (2006) 16117-16127
47. Minty A., Dumont X., Kaghad M., and Caput D. Covalent modification of p73alpha by SUMO-1. Two-hybrid screening with p73 identifies novel SUMO-1-interacting proteins and a SUMO-1 interaction motif. J. Biol. Chem. 275 (2000) 36316-36323
48. Schneikert J., Peterziel H., Defossez P.A., Klocker H., Launoit Y., and Cato A.C. Androgen receptor-Ets protein interaction is a novel mechanism for steroid hormone-mediated down-modulation of matrix metalloproteinase expression. J. Biol. Chem. 271 (1996) 23907-23913
49. Ghisletti S., Huang W., Ogawa S., Pascual G., Lin M.E., Willson T.M., Rosenfeld M.G., and Glass C.K. Parallel SUMOylation-dependent pathways mediate gene- and signal-specific transrepression by LXRs and PPARgamma. Mol. Cell 25 (2007) 57-70
50. Pascual G., Fong A.L., Ogawa S., Gamliel A., Li A.C., Perissi V., Rose D.W., Willson T.M., Rosenfeld M.G., and Glass C.K. A SUMOylation-dependent pathway mediates transrepression of inflammatory response genes by PPAR-gamma. Nature 437 (2005) 759-763
51. Yang S.H., and Sharrocks A.D. SUMO promotes HDAC-mediated transcriptional repression. Mol. Cell 13 (2004) 611-617
52. Rosendorff A., Sakakibara S., Lu S., Kieff E., Xuan Y., Dibacco A., Shi Y., and Gill G. NXP-2 association with SUMO-2 depends on lysines required for transcriptional repression. Proc. Natl. Acad. Sci. U. S. A. 103 (2006) 5308-5313
53. Yang S.H., Vickers E., Brehm A., Kouzarides T., and Sharrocks A.D. Temporal recruitment of the mSin3A-histone deacetylase corepressor complex to the ETS domain transcription factor Elk-1. Mol. Cell. Biol. 21 (2001) 2802-2814